Nuzenio

Public Offering

Public Offering news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 18 publisher sources 100/100 entity strength

Latest news

Austin Public Health offering 3 vaccine clinics during August - KXAN AustinKXAN Austin · Sat, 08 Aug 2026 15:55:36 GMTE.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen - The Manila TimesThe Manila Times · Sat, 08 Aug 2026 15:10:59 GMTU92 Energy Announces Filing of Final Short Form Prospectus in Connection with Public Offering - Investing News NetworkInvesting News Network · Fri, 07 Aug 2026 21:25:35 GMTiSpecimen Inc. Closes $5 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 20:40:00 GMTLatham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering - Latham & Watkins LLPLatham & Watkins LLP · Fri, 07 Aug 2026 20:34:02 GMTBraveheart Bio Shares Begin Nasdaq Trading After $439.9M IPO - stocktitan.netstocktitan.net · Fri, 07 Aug 2026 20:05:00 GMTRiver City Bank Announces Closing of Initial Public Offering - Business WireBusiness Wire · Fri, 07 Aug 2026 20:00:00 GMTSpaceX shares rise even as company insiders get a chance to sell for the first time - WHEC.comWHEC.com · Fri, 07 Aug 2026 19:42:55 GMT

Timeline

Sat, 08 Aug 2026 15:55:36 GMTAustin Public Health offering 3 vaccine clinics during August - KXAN Austin
Sat, 08 Aug 2026 15:10:59 GMTE.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen - The Manila Times
Fri, 07 Aug 2026 21:25:35 GMTU92 Energy Announces Filing of Final Short Form Prospectus in Connection with Public Offering - Investing News Network
Fri, 07 Aug 2026 20:40:00 GMTiSpecimen Inc. Closes $5 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Fri, 07 Aug 2026 20:34:02 GMTLatham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering - Latham & Watkins LLP
Fri, 07 Aug 2026 20:05:00 GMTBraveheart Bio Shares Begin Nasdaq Trading After $439.9M IPO - stocktitan.net

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Public Offering.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

18 distinct publisher/source names are currently connected to this entity page.